The "Angel Project" na-enyere aka nkenke ọgwụ ibelata ịda ogbenye.
Na February 19, 2023, Central Committee of the Chinese People's Political Consultative Conference (CPPCC) na Siemens jikọrọ aka kwalite Guardian Angel Project na Gansu Province, na-enye ngwá ọrụ dị elu ma na-enye ngwá ọrụ ahụike dị elu na mpaghara mpaghara.Ọrụ ahụ ekerewo òkè dị mkpa n'ịmejupụta oghere dị n'ime nchọpụta na akụrụngwa ọgwụgwọ na teknụzụ na ọkwa dị elu nke ụlọ ọrụ ahụike mpaghara, na-emeziwanye nyocha na ọgwụgwọ nke ụlọ ọrụ ahụike mbụ, na-ebelata ihe isi ike n'ịchọ ọgwụgwọ maka ọha na eze. .
E mepela klaasị ọzụzụ ahụike na ebumnuche nke imeziwanye ndị otu ọkachamara ahụike na ọkwa teknụzụ ha, yana ịkwalite ikike ndị ọrụ ahụike ịgwọ na ịzọpụta ndụ.N'ọzọ na-esote, a ga-eme usoro mmemme ọzụzụ iji kwalite njikwa ahụike na nyocha na ike ọgwụgwọ na mpaghara niile.Epiprobe gbasoro "Angel Project" n'ime Wuwei, na-enye nkà na ụzụ ọhụrụ maka nchọpụta ọrịa cancer na ihe nrịbama cancer zuru ezu iji jeere ndị obodo ozi ma nye aka na mmepe nke ụlọ ọrụ ahụike na ahụike.
Epiprobe soro "Angel Project" banye Wuwei.
Wuwei dị na etiti mpaghara Gansu na ugwu ọdịda anyanwụ China ma nwee ogologo akụkọ ihe mere eme.A maara ya dị ka obodo akụkọ ihe mere eme na omenala obodo.Otú ọ dị, n'agbanyeghị akụkọ ihe mere eme ya bara ụba, ọkwa nlekọta ahụike na mpaghara ahụ dị ntakịrị azụ.Iji meziwanye ụkpụrụ ahụike mpaghara ma chebe ahụike nke ndị obodo, Epiprobe gbasoro Siemens Medical na "Angel Project" nke ndị China na-ahụ maka ndụmọdụ ndọrọ ndọrọ ọchịchị n'ime Wuwei, na-enye ọrụ nchọpụta methylation.
Iji meziwanye ọkwa nchọpụta ọrịa kansa nke ụlọ ọgwụ dị na Wuwei, Epiprobe na-arụkọ ọrụ ọnụ na ụlọ ọgwụ mpaghara iji nye ọzụzụ teknụzụ nchọpụta methylation, na-enye ndị dọkịta obodo usoro ọhụrụ maka nyocha ọrịa kansa na mbụ, nke ziri ezi na nke dị irè karị.
Ihe nrịbama ọrịa kansa TAGMe® na-eduga ahụike ụmụ nwanyị mpaghara.
Ọrịa cancer nke usoro ọmụmụ na ụmụ nwanyị dị oke njọ.Ihe dị ka 140,000 ọhụrụ ọrịa cancer cervical na 80,000 ọhụrụ ọrịa cancer endometrial ka a na-achọpụta kwa afọ, ọkwa nke mbụ na nke abụọ n'otu n'otu na ọrịa cancer nke usoro ọmụmụ.N'ihi oke na ụzọ nchọpụta, ọtụtụ ọrịa cancer cervical na endometrial na-achọpụta na ọkwa dị elu.
Dabere na ọnụ ọgụgụ nyocha, ọnụ ọgụgụ ndụ afọ ise maka ọrịa kansa cervical dị elu bụ naanị 40%.Ọ bụrụ na enwere ike ịme nchọpụta ahụ n'oge a na-ebute ọrịa cancer, ọnụ ọgụgụ ọgwụgwọ ahụ nwere ike iru 100%, na-enweta n'ezie ihe mgbaru ọsọ nke iwepụ ọrịa cancer cervical na ịzọpụta ndụ ndị ọzọ.
Iji nyere ụmụ nwanyị nọ na Wuwei aka igbochi na ịchịkwa ọrịa kansa cervical na endometrial, Epiprobe gbasoro Siemens Healthcare na “Angel Project” nke Democratic League na Wuwei, na-eweta teknụzụ nchọpụta methylation iji chebe ahụike ụmụ nwanyị mpaghara.
Epiprobe ewepụtala ihe pụrụ iche pan-cancer biomarker, TAGMe, na usoro Me-qPCR nke na-achọghị ọgwụgwọ metabisulfite, iji mepụta TAGMe DNA Methylation Detection Kits maka ọrịa kansa ịmụ nwa.Ihe ngosi ngwa ya zuru oke nwere ike inyere ọtụtụ ụmụ nwanyị aka izere iyi egwu nke cancer cervical na endometrial.
Ihe atụ nke 1: Nnyocha mbụ nke ọrịa cancer (nchọpụta mmalite nke ọnya tupu ọrịa kansa)
Ihe atụ nke 2: Ọnụ ọgụgụ ndị HPV nwere nnukwu ihe ize ndụ
Ihe atụ nke 3: Nchọpụta enyemaka nke ndị mmadụ na-enyo enyo
Ihe atụ nke 4: Nyocha ihe ize ndụ nke ọnya ndị fọdụrụ mgbe ịwachara ahụ
Ihe atụ nke 5: Nleba anya nlọghachi nke ndị mmadụ mgbe arụchara ọrụ gasịrị
Epiprobe kwadoro ịhụ n'anya ma na-agbaso "Angel Project".Malite na ọdụ Wuwei, ọ na-agbasa nlekọta ahụike nye ọtụtụ mmadụ.
Oge nzipu: Mee-04-2023